Stay Ahead of Market & Policy Shifts

Financial & Policy Research Insights

Filters

Sector: Healthcare

Slight Tailwinds for Chain Drug Stores and Pharmacies

Slight Tailwinds for Chain Drug Stores and Pharmacies

Policy & Legal
This research explores how potential PBM reform, IRA implementation, and pricing policy shifts may provide moderate tailwinds for retail pharmacy chains like CVS, WBA, and RiteAid in 2025.
Read more
UK Conference Call Takeaways for Healthcare REITs

UK Conference Call Takeaways for Healthcare REITs

Policy & Legal, Research
Washington Analysis Healthcare Team hosted a conference call with a leading UK-based strategic advisor to understand better the potential...
Read more
Healthcare & Consumer Goods Policy Day 2025: Medicaid, Vaccines & RFK Jr.’s MAHA Priorities

Healthcare & Consumer Goods Policy Day 2025: Medicaid, Vaccines & RFK Jr.’s MAHA Priorities

Policy & Legal, Video
An exclusive policy event in Washington, D.C., covering key legislative developments in healthcare, consumer goods, Medicaid, Medicare, and RFK Jr.'s Make America Healthy Again priorities.
Read more
2025: The Biggest Year in Healthcare – Critical Policy Shifts & Market Impacts

2025: The Biggest Year in Healthcare – Critical Policy Shifts & Market Impacts

Policy & Legal, Research
2025 will bring major healthcare policy shifts, impacting ACA subsidies, Medicare payments, drug pricing, and REITs.
Read more
Health Care Equipment & Supplies: Solventum STARS Initiation

Health Care Equipment & Supplies: Solventum STARS Initiation

Fundamental, Research
On October 14, coverage was initiated for Solventum Corporation (SOLV) with...
Read more
Assessing LLY’s Competition in the Obesity Space and New

Assessing LLY’s Competition in the Obesity Space and New

Fundamental, Research
The obesity therapy market is rapidly growing, particularly following Eli Lilly and Novo Nordisk’s success with GLP-1 drugs.
Read more
Johnson & Johnson Q1 Earnings Review and Insights on Key Issues

Johnson & Johnson Q1 Earnings Review and Insights on Key Issues

Fundamental, Research
Johnson & Johnson announced Q1 2024 earnings on April 16, 2024, broadly aligning...
Read more
Health Care ETFs

Health Care ETFs

ETF & Mutual Fund, Research
The U.S. health care industry endured challenging conditions in 2023...
Read more
Large U.S. Pharmaceuticals: Is M&A the Remedy for Looming Risks Ahead?

Large U.S. Pharmaceuticals: Is M&A the Remedy for Looming Risks Ahead?

Fundamental, Research
Despite the high interest rate environment during 2023, M&A activity in the health care industry...
Read more
European Materials: Unlocking the Value in North America

European Materials: Unlocking the Value in North America

Fundamental, Research
Holcim intends to spin off its U.S. business, which currently represents about...
Read more